Informazioni sul prodotto
- BTRX 331540
- 1-(6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)piperidin-4-amine
- CYM 53093
- 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-
- 1-[6-Ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)-4-piperidinamine
BTRX-335140 is a novel compound that has been shown to modulate the opioid receptor. It is orally active and has a pharmacokinetic profile that is characterized by rapid absorption and elimination. The compound binds to the opioid receptor, modulating its activity. Electrophysiological studies have demonstrated that BTRX-335140 exhibits high affinity for the tegmental and ventral portions of the brain, but not the dorsal region. It also has been shown to act as an antagonist of dopamine receptors, which may contribute to some of its antidepressant effects.
Proprietà chimiche
Richiesta tecnica su: 3D-UPD61414 BTRX-335140
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
